日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Unveiling TRIB3: A new mediator in MET-driven hepatocellular carcinoma progression: Editorial on "MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation"

揭示 TRIB3:MET 驱动的肝细胞癌进展中的新介质:关于“MET 通过促进 TRIB3 介导的 FOXO1 降解来促进肝细胞癌发展”的社论

Chan, Many Sze Man; Lee, Terence Kin Wah

Reply to correspondence 1 on "MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation"

回复关于“MET通过促进TRIB3介导的FOXO1降解来促进肝细胞癌发展”的来信1

Chan, Many Sze Man; Lee, Terence Kin Wah

Harnessing the microbiome: unveiling the influence of the gut microbiota on hepatobiliary cancer therapeutic strategies

利用微生物组:揭示肠道菌群对肝胆癌治疗策略的影响

Li, Melody Yusong; Wu, Xue Qian; Lee, Terence Kin Wah

Reply to correspondence on "UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma"

回复关于“UBE2S:肝细胞癌中HIF-1α诱导代谢重编程的新型驱动因子”的来信

Lei, Martina Mang Leng; Lee, Terence Kin Wah

UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma: Editorial on "UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL"

UBE2S:肝细胞癌中 HIF-1α 诱导代谢重编程的新型驱动因子:关于“UBE2S 通过增强 VHL 的 E3 酶非依赖性多聚泛素化促进肝细胞癌中的糖酵解”的社论

Lei, Martina Mang Leng; Lee, Terence Kin Wah

Identification of KCTD17 as a Ras stabilizer in hepatocellular carcinoma: Editorial on "KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression"

鉴定 KCTD17 为肝细胞癌中的 Ras 稳定剂:关于“KCTD17 介导的 Ras 稳定促进肝细胞癌进展”的社论

Leung, Rainbow Wing Hei; Lee, Terence Kin Wah

TM4SF1 - A new immune target for treatment of hepatocellular carcinoma: Editorial on "Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma"

TM4SF1——肝细胞癌治疗的新免疫靶点:社论“靶向TM4SF1促进肿瘤衰老,增强CD8+ T细胞在肝细胞癌中的细胞毒性功能”

Yuan, Chen Rui; Lee, Terence Kin Wah

Deciphering adenosine signaling in hepatocellular carcinoma: Pathways, prognostic models, and therapeutic implications

解析肝细胞癌中腺苷信号传导:通路、预后模型和治疗意义

Yang, Huihai; Lei, Martina Mang Leng; Xie, Longfei; Shou, Yinuo; Lee, Terence Kin Wah

Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma

野生型KRAS激活驱动肝细胞癌逃避干扰素介导的免疫反应并产生免疫治疗耐药性。

Martina Mang Leng Lei ,Carmen Oi Ning Leung ,Rainbow Wing Hei Leung ,Xue Qian Wu ,Katherine Po Sin Chung ,Catherine Yu Jia Gu ,Mandy Sze Man Chan ,Wing Ki Chau ,Quan Hua Mu ,Kai Yu Ng ,Man Tong ,Jing Ping Yun ,Jia Ming Nickolas Teo ,Guang Sheng Ling ,Patrick Pak Chun Wong ,Stephen Lam Chan ,Zhe Wen Xiong ,Alfred Sze Lok Cheng ,Jin Ding ,Stephanie Ma ,Terence Kin Wah Lee

Adipocyte-derived FABP4 promotes metabolism-associated steatotic liver-induced hepatocellular carcinoma by driving ITGB1-mediated β-catenin activation

脂肪细胞来源的FABP4通过驱动ITGB1介导的β-catenin激活,促进代谢相关的脂肪肝诱导的肝细胞癌的发生。

Leung, Carmen Oi Ning; Gurung, Shilpa; Chung, Katherine Po Sin; Leung, Rainbow Wing Hei; Lei, Martina Mang Leng; Chan, Mandy Sze Man; Muliawan, Gregory Kenneth; Khan, Shakeel Ahmad; Wu, Xue Qian; Yu, Jun; Zhu, Hui Lian; Lu, Yin Ying; Ma, Stephanie; Wu, Xiaoping; Hoo, Ruby Lai Chong; Lee, Terence Kin Wah